The National Institutes of Health (NIH) is offering this grant to support efficient, large-scale pragmatic trials and implementation studies. Its primary purpose is to improve health outcomes for underserved U.S. patient populations by assessing healthcare strategies and clinical practices in “real world” settings. This phased UG3/UH3 cooperative research opportunity begins with a one-year planning phase, potentially transitioning to an implementation phase. Projects must propose interventions embedded within healthcare delivery systems and be conducted across three or more participating healthcare systems serving underserved communities. Grantees will work with the NIH Health Care Systems Research Collaboratory, generating results to inform policymakers, payers, doctors, and patients.
Opportunity ID: 336130
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AT-22-001 |
| Funding Opportunity Title: | NIH Health Care Systems Research Collaboratory – Pragmatic and Implementation Trials of Embedded Interventions (UG3/UH3, Clinical Trials Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 14, 2021 |
| Last Updated Date: | Oct 14, 2021 |
| Original Closing Date for Applications: | Jun 17, 2022 |
| Current Closing Date for Applications: | Jun 17, 2022 |
| Archive Date: | Jul 23, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses State governments Special district governments Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities City or township governments Private institutions of higher education Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages UG3/UH3 phased cooperative research applications to conduct efficient, large-scale pragmatic trials or implementation studies that focus on improving health outcomes for underserved US patient populations. Awards made under this FOA will initially support a one-year milestone-driven planning phase (UG3), with possible transition to an implementation phase (UH3). UG3 projects that have met the scientific milestone and feasibility requirements may transition to the UH3 phase. The UG3/UH3 application must be submitted as a single application, following the instructions described in this FOA. The overall goal of this initiative is to support the “real world” assessment of health care strategies and clinical practices and procedures in health care systems (HCS) that lead to improved care for underserved populations; who have suffered a disproportionate disease burden in the US. Results from the pragmatic studies supported by this FOA should inform policy makers, payers, doctors and patients across diverse patient care settings. This FOA requires that the intervention under study be embedded into health care delivery system, real world settings. Studies can propose to integrate multi-modal or multiple interventions that have demonstrated efficacy into HCS; or implement HCS changes to improve adherence to evidence-based guidelines. Trials or studies should be conducted across three or more health care systems (HCS) that provide care to underserved patient populations; and will become part of and work with the NIH HCS Research Collaboratory. The NIH HCS Research Collaboratory Program has established a Collaboratory Coordinating Center (CCC) that is providing national leadership and technical expertise in all aspects of research with HCS (See Companion FOA). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-22-001.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 336130 Full Announcement-RFA-AT-22-001 -> RFA-AT-22-001-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00269330 | Nov 15, 2021 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270474 | Nov 18, 2021 | Jun 17, 2022 | View |
Package 1
Mandatory forms
336130 RR_SF424_2_0-2.0.pdf
336130 PHS398_CoverPageSupplement_5_0-5.0.pdf
336130 RR_OtherProjectInfo_1_4-1.4.pdf
336130 PerformanceSite_2_0-2.0.pdf
336130 RR_KeyPersonExpanded_2_0-2.0.pdf
336130 RR_Budget_1_4-1.4.pdf
336130 PHS398_ResearchPlan_4_0-4.0.pdf
336130 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
336130 RR_SubawardBudget30_1_4-1.4.pdf
336130 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
336130 RR_SF424_5_0-5.0.pdf
336130 PHS398_CoverPageSupplement_5_0-5.0.pdf
336130 RR_OtherProjectInfo_1_4-1.4.pdf
336130 PerformanceSite_4_0-4.0.pdf
336130 RR_KeyPersonExpanded_4_0-4.0.pdf
336130 RR_Budget_3_0-3.0.pdf
336130 PHS398_ResearchPlan_4_0-4.0.pdf
336130 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
336130 RR_SubawardBudget30_3_0-3.0.pdf
336130 PHS_AssignmentRequestForm_3_0-3.0.pdf